Rocket Pharmaceuticals, Inc. (RCKT): 4 insider purchases in the last two years (1 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 6, 2026 | Bjork Elisabeth Director | 10,000 | $3.44 | $34.4K | no history |
| Aug 27, 2025 | Bjork Elisabeth Director | 10,000 | $3.41 | $34.1K | no history |
| Apr 14, 2025 | Shah Gaurav Director, Officer | 20,000 | $5.08 | $101.6K | opportunistic |
| Apr 10, 2025 | Patel Kinnari Officer | 21,099 | $4.70 | $99.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.